Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

What's Happening in the Lab?

Latest News

July 24, 2024 Eric Allenspach, Taylor Watson, Stacey DeBoer, Jacob Medjo
Lab adventure to the Mariners game! Photo by Eric Allenspach.
May 23, 2024 Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans
Lab collaboration helps link human lupus-like features to mutation in the UNC93B1 gene.
December 12, 2023 Eric Allenspach, Stacey DeBoer, Taylor Watson and Jacob Medjo
At the Seattle Children's Research Institute holiday party. Photo by Puget Sound Photo Booth Co.
July 22, 2023 Somatic Genetic Reversion of a Duplication Event in IL2RG in Siblings
Congratulations to Patricia and Stacey for publishing a fascinating example of somatic genetic rescue.
July 7, 2023 Rare Disorder Research Yields Insights into Immune Dysregulation, Drug Approaches
Seattle Children’s researchers and colleagues have identified a new driver of autoimmunity that may be relevant to many diseases, including lupus.
September 19, 2022 September 2022
Undergraduates Jessica Li and Josh Vo join the lab at student-researchers. Welcome!
June 10, 2022 June 2022
Jake joins the Allenspach Lab. Welcome to the team!
March 16, 2022 March 2022
Our paper describing an Artic variant in the IFNAR2 gene leading to life-threatening viral disease was accepted in JEM.

Contact Us

Eric Allenspach, MD, PhD
Eric.Allenspach@seattlechildrens.org
206-884-1522

Physical address

Center for Immunity and Immunotherapies
1920 Terry Ave.
Seattle, WA 98101

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.